nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYSLTR1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0504	0.0504	CbGpPWpGaD
Montelukast—CYP2A6—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.0452	0.0452	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0451	0.0451	CbGpPWpGaD
Montelukast—CYSLTR1—Endothelins—CDC42—adrenal gland cancer	0.0392	0.0392	CbGpPWpGaD
Montelukast—ALOX5—Eicosanoid Synthesis—PTGS2—adrenal gland cancer	0.0337	0.0337	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0334	0.0334	CbGpPWpGaD
Montelukast—CYSLTR1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0302	0.0302	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.027	0.027	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0254	0.0254	CbGpPWpGaD
Montelukast—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—adrenal gland cancer	0.0225	0.0225	CbGpPWpGaD
Montelukast—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0223	0.0223	CbGpPWpGaD
Montelukast—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0201	0.0201	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.02	0.02	CbGpPWpGaD
Montelukast—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—adrenal gland cancer	0.0191	0.0191	CbGpPWpGaD
Montelukast—ALOX5—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.0187	0.0187	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0178	0.0178	CbGpPWpGaD
Montelukast—PTGS1—Overview of nanoparticle effects—PTGS2—adrenal gland cancer	0.0176	0.0176	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0152	0.0152	CbGpPWpGaD
Montelukast—PTGS1—Eicosanoid Synthesis—PTGS2—adrenal gland cancer	0.0146	0.0146	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0144	0.0144	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—TSHR—adrenal gland cancer	0.0136	0.0136	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0131	0.0131	CbGpPWpGaD
Montelukast—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.0122	0.0122	CbGpPWpGaD
Montelukast—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.0122	0.0122	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.0119	0.0119	CbGpPWpGaD
Montelukast—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0112	0.0112	CbGpPWpGaD
Montelukast—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.0106	0.0106	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00861	0.00861	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00843	0.00843	CbGpPWpGaD
Montelukast—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00832	0.00832	CbGpPWpGaD
Montelukast—PTGS1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00812	0.00812	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—GNAS—adrenal gland cancer	0.0079	0.0079	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00782	0.00782	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—SDHB—adrenal gland cancer	0.00782	0.00782	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00771	0.00771	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00768	0.00768	CbGpPWpGaD
Montelukast—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00735	0.00735	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00717	0.00717	CbGpPWpGaD
Montelukast—PTGS1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00714	0.00714	CbGpPWpGaD
Montelukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00701	0.00701	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00699	0.00699	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00697	0.00697	CbGpPWpGaD
Montelukast—CYP2A6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00675	0.00675	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00674	0.00674	CbGpPWpGaD
Montelukast—CYP2A6—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00638	0.00638	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00615	0.00615	CbGpPWpGaD
Montelukast—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00569	0.00569	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00543	0.00543	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00533	0.00533	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—POMC—adrenal gland cancer	0.00532	0.00532	CbGpPWpGaD
Montelukast—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00525	0.00525	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00517	0.00517	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—SDHD—adrenal gland cancer	0.00504	0.00504	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—RRM1—adrenal gland cancer	0.00504	0.00504	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.005	0.005	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00467	0.00467	CbGpPWpGaD
Montelukast—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00463	0.00463	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00462	0.00462	CbGpPWpGaD
Montelukast—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00461	0.00461	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00447	0.00447	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.0044	0.0044	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00432	0.00432	CbGpPWpGaD
Montelukast—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00427	0.00427	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00424	0.00424	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00423	0.00423	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TSHR—adrenal gland cancer	0.00412	0.00412	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00406	0.00406	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MEN1—adrenal gland cancer	0.00387	0.00387	CbGpPWpGaD
Montelukast—PTGS1—Biological oxidations—POMC—adrenal gland cancer	0.00379	0.00379	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—MED12—adrenal gland cancer	0.00376	0.00376	CbGpPWpGaD
Montelukast—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00375	0.00375	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00366	0.00366	CbGpPWpGaD
Montelukast—CYP2A6—Biological oxidations—POMC—adrenal gland cancer	0.00358	0.00358	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SDHB—adrenal gland cancer	0.00339	0.00339	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00336	0.00336	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SDHB—adrenal gland cancer	0.00321	0.00321	CbGpPWpGaD
Montelukast—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00305	0.00305	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00301	0.00301	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00296	0.00296	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PRKACA—adrenal gland cancer	0.00274	0.00274	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—POMC—adrenal gland cancer	0.00273	0.00273	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00268	0.00268	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00267	0.00267	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDC42—adrenal gland cancer	0.00251	0.00251	CbGpPWpGaD
Montelukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00247	0.00247	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	0.00245	0.00245	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF2—adrenal gland cancer	0.00242	0.00242	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GNAS—adrenal gland cancer	0.0024	0.0024	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00236	0.00236	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.00234	0.00234	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GNAS—adrenal gland cancer	0.00222	0.00222	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SDHB—adrenal gland cancer	0.00219	0.00219	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SDHD—adrenal gland cancer	0.00218	0.00218	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—RRM1—adrenal gland cancer	0.00218	0.00218	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ABCB1—adrenal gland cancer	0.00218	0.00218	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SDHD—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—RRM1—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TERT—adrenal gland cancer	0.00201	0.00201	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.00199	0.00199	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00192	0.00192	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.00178	0.00178	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—BAD—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MED12—adrenal gland cancer	0.00163	0.00163	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—POMC—adrenal gland cancer	0.00161	0.00161	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—BRAF—adrenal gland cancer	0.00159	0.00159	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MED12—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—POMC—adrenal gland cancer	0.0015	0.0015	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00146	0.00146	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SDHD—adrenal gland cancer	0.00141	0.00141	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—RRM1—adrenal gland cancer	0.00141	0.00141	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS2—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PRKACA—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MED12—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GNAS—adrenal gland cancer	0.000963	0.000963	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ABCB1—adrenal gland cancer	0.000945	0.000945	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00094	0.00094	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EGFR—adrenal gland cancer	0.000912	0.000912	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GNAS—adrenal gland cancer	0.00091	0.00091	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	0.000893	0.000893	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000856	0.000856	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	0.000767	0.000767	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—adrenal gland cancer	0.000766	0.000766	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000765	0.000765	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000757	0.000757	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000757	0.000757	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00075	0.00075	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—POMC—adrenal gland cancer	0.000648	0.000648	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000624	0.000624	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GNAS—adrenal gland cancer	0.000622	0.000622	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—POMC—adrenal gland cancer	0.000613	0.000613	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00061	0.00061	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	0.00061	0.00061	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000565	0.000565	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—adrenal gland cancer	0.000517	0.000517	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000506	0.000506	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000497	0.000497	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	0.000489	0.000489	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—POMC—adrenal gland cancer	0.000419	0.000419	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000412	0.000412	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000341	0.000341	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	0.000334	0.000334	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000334	0.000334	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000328	0.000328	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.000272	0.000272	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000225	0.000225	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.000179	0.000179	CbGpPWpGaD
